Vest Financial LLC Trims Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Vest Financial LLC decreased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 113,736 shares of the pharmacy operator’s stock after selling 19,602 shares during the period. Vest Financial LLC’s holdings in Walgreens Boots Alliance were worth $1,061,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. First Financial Corp IN grew its holdings in Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 885 shares during the period. Golden State Wealth Management LLC purchased a new position in Walgreens Boots Alliance during the fourth quarter worth approximately $26,000. TD Private Client Wealth LLC grew its stake in shares of Walgreens Boots Alliance by 8,670.3% during the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 3,208 shares during the period. Sentry Investment Management LLC purchased a new stake in shares of Walgreens Boots Alliance during the 3rd quarter valued at $30,000. Finally, Eastern Bank acquired a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth $33,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock opened at $10.12 on Monday. The firm has a 50 day moving average of $10.22 and a 200-day moving average of $9.81. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $22.96. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The company has a market cap of $8.75 billion, a price-to-earnings ratio of -0.99, a price-to-earnings-growth ratio of 1.26 and a beta of 0.65.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same period last year, the business posted $0.66 earnings per share. Walgreens Boots Alliance’s revenue was up 7.6% on a year-over-year basis. On average, equities analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Evercore ISI increased their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. TD Cowen lowered their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, October 22nd. Royal Bank of Canada upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Jefferies Financial Group cut their price objective on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday, October 23rd. Finally, UBS Group raised their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus price target of $13.19.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.